From: Bone marrow-derived progenitor cells in end-stage lung disease patients
All included transplant | |
---|---|
recipients | |
n = 154 | |
Recipient | |
Age at transplantation (SD), yrs | 50.9 ± 14.9 |
Gender, total (%) | |
Male | 89 (57.8) |
Female | 65 (42.2) |
Diagnosis | |
COPD/Emphysema + Alpha-1 Antitrypsin Deficiency | 43 (27.9) |
Pulmonary Fibrosis + Scleroderma | 52 (33.8) |
Cystic Fibrosis + Bronchiectasis | 34 (22.1) |
PPH + Eisenmenger’s + Congenital Abnormalities | 14 (9.1) |
Retransplant + BO | 6 (3.9) |
Other | 5 (3.2) |
Diabetes mellitus | |
Non-Insulin Dependent | 17 (11.0) |
Insulin Dependent | 20 (13.0) |
No Diabetes | 117 (76.0) |
BMI, mean (SD), kg/rn2 | 23.6 ± 4.8 |
Graft Number | |
First | 148 (96.1) |
Second | 6 (3.9) |